http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-1240853-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c646f75c4f7c6349f35c8fe01934921 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- |
| filingDate | 1990-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1993-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2712fbc3311f345d75951db2e53f13c |
| publicationDate | 1993-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | IT-1240853-B |
| titleOfInvention | PHARMACEUTICAL COMPOSITION SUITABLE FOR INTRANASAL ADMINISTRATION INCLUDING CALCITONIN AND AN ACYL-CARNITINE |
| abstract | This pharmaceutical compound administered nasally and containing calcitonin which was the main active ingredient and a acylcarnitine which is an agent that increases the absorption of the main ingredient by the mucous membrane. |
| priorityDate | 1990-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.